|
 |
Do patients at high risk of nonsudden cardiac death benefit from prophylactic ICD therapy?
PA Scott, LD Sterns... - Current Opinion in Cardiology, 2012 - Abstract Purpose of review: Randomized controlled trials have established that prophylactic implantable cardioverter defibrillator (ICD) therapy improves survival in patients with reduced left ventricular ejection fraction (LVEF). However, mortality reduction is not ...
More Details:
Do patients at high risk of nonsudden cardiac death benefit from prophylactic ICD therapy? |
|
|
